跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IPROVENT INHALER 20 MCG/PUFF - HSA Drug Approval Details
Approvals
/
HSA
/
IPROVENT INHALER 20 MCG/PUFF
Approved
THERAPEUTIC
IPROVENT INHALER 20 MCG/PUFF
LABORATORIO ALDO-UNIÓN S.L. (SPAIN)
🇸🇬 Health Sciences Authority
Approval Date
Oct 23, 2012
Approval ID
30a9b2237c4d127b
Company
LABORATORIO ALDO-UNIÓN S.L. (SPAIN)
Type
Therapeutic
Approval Details
Approval Id
30a9b2237c4d127b
Drug Name
IPROVENT INHALER 20 MCG/PUFF
Product Name
IPROVENT INHALER 20 MCG/PUFF
Approval Number
SIN14257P
Approval Date
2012-10-23
Registrant
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence Holder
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
AEROSOL, METERED
Route Of Administration
RESPIRATORY (INHALATION)
Atc Code
R03BB01
Atc Item Name
ipratropium bromide
Pharma Manufacturer Name
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Active Ingredients
Ipratropium bromide monohydrate 21 mcg eqv to anhydrous Ipratropium bromide
20 mcg/dose
Ipratropium bromide monohydrate 21 mcg eqv to anhydrous Ipratropium bromide
20 mcg/dose
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Oct 23, 2012
Approval ID
30a9b2237c4d127b
Type
Therapeutic
Back to HSA Approvals